FIELD: chemistry.
SUBSTANCE: invention relates to novel compounds selected from the group
as well as to medicines based thereon.
EFFECT: obtaining novel compounds with inhibitory activity against tankyrase (TANK).
2 cl, 2 tbl, 8 ex
Title | Year | Author | Number |
---|---|---|---|
PHTHALAZINE DERIVATIVES | 2014 |
|
RU2663623C2 |
QUINAZOLINONE DERIVATIVES AS PARP INHIBITORS | 2013 |
|
RU2650107C2 |
PIPERIDINE UREA DERIVATIVES | 2014 |
|
RU2666894C2 |
(AZA-)ISOQUINOLINE DERIVATIVES | 2013 |
|
RU2654216C2 |
OXOQUINAZOLINYL-BUTANAMIDE DERIVATIVES | 2014 |
|
RU2669393C2 |
IMIDAZOLONYL QUINOLINES AND USE THEREOF AS KINASE ATM INHIBITORS | 2016 |
|
RU2743343C2 |
PHTHALAZINE KETONE DERIVATIVE, METHOD OF OBTAINING THEREOF AND PHARMACEUTICAL APPLICATION | 2011 |
|
RU2564527C2 |
ARYLQUINAZOLINES | 2014 |
|
RU2701193C2 |
BICYCLIC AGONISTS OF THE INTERFERON GENE STIMULATOR STING | 2020 |
|
RU2800072C1 |
PYRAZOLE-BASED MAGL INHIBITORS | 2018 |
|
RU2789157C2 |
Authors
Dates
2018-11-20—Published
2014-12-03—Filed